These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 38562304)

  • 1. Molecular pathways in experimental glaucoma models.
    Bugara K; Pacwa A; Smedowski A
    Front Neurosci; 2024; 18():1363170. PubMed ID: 38562304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology.
    Basavarajappa D; Galindo-Romero C; Gupta V; Agudo-Barriuso M; Gupta VB; Graham SL; Chitranshi N
    Mol Aspects Med; 2023 Dec; 94():101216. PubMed ID: 37856930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.
    Kimura A; Namekata K; Guo X; Noro T; Harada C; Harada T
    Oxid Med Cell Longev; 2017; 2017():2817252. PubMed ID: 28270908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlarged Optic Nerve Axons and Reduced Visual Function in Mice with Defective Microfibrils.
    Wu HJ; Hazlewood RJ; Kuchtey J; Kuchtey RW
    eNeuro; 2018; 5(5):. PubMed ID: 30406200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells.
    Ju WK; Perkins GA; Kim KY; Bastola T; Choi WY; Choi SH
    Prog Retin Eye Res; 2023 Jul; 95():101136. PubMed ID: 36400670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy Strategies for Glaucomatous Neurodegeneration.
    Lani-Louzada R; Dias MS; Linden R; Ribas VT; Petrs-Silva H
    Curr Gene Ther; 2021; 21(5):362-381. PubMed ID: 33573569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering.
    Tribble JR; Hui F; Quintero H; El Hajji S; Bell K; Di Polo A; Williams PA
    Mol Aspects Med; 2023 Aug; 92():101193. PubMed ID: 37331129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for neuro protection in glaucoma.
    Xuejiao Y; Junwei Y
    Front Cell Dev Biol; 2022; 10():983195. PubMed ID: 36187483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New solutions for old challenges in glaucoma treatment: is taurine an option to consider?
    Iezhitsa I; Agarwal R
    Neural Regen Res; 2021 May; 16(5):967-971. PubMed ID: 33229737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser
    Means JC; Lopez AA; Koulen P
    Cell Mol Neurobiol; 2020 Aug; 40(6):911-926. PubMed ID: 31919747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of potential novel glaucoma therapeutic options independent of intraocular pressure.
    Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ
    Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-region-Specific Optic Nerve Head Glial Activation in Glaucoma.
    Oikawa K; Ver Hoeve JN; Teixeira LBC; Snyder KC; Kiland JA; Ellinwood NM; McLellan GJ
    Mol Neurobiol; 2020 Jun; 57(6):2620-2638. PubMed ID: 32266645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
    Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
    J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated retinal glia mediated axon regeneration in experimental glaucoma.
    Lorber B; Guidi A; Fawcett JW; Martin KR
    Neurobiol Dis; 2012 Jan; 45(1):243-52. PubMed ID: 21867754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.